PriMera Scientific Medicine and Public Health (ISSN: 2833-5627)

Research Article

Volume 5 Issue 4

Prevalence and Correlation between HbA1c Control and Duration of Diabetes with Blindness due to Progression of Advanced Diabetic, Libya

Abdolmejed Fathy and Khalid AK Elmajri*

October 04, 2024

View PDF

Abstract

A prospective cross-sectional study of diabetic patients registered at Eye department of Tobruk medical center in Tobruk-Libya between (01.06.2023 to 29.02.2024). Data was collected using self-administered questionnaire. Grading of DR was done by slit-lamp examination and Fundoscopy by ophthalmologist. Descriptive analysis included percentage and mean, median, and p-value by using SPSS 25. There were 85 diabetic patients, ages ranged between 30 and 90 years, with a mean of 58, the majority (97.6%) were Libyan nationality living in Tobruk (98.3 %). There were 86 females. that patients with duration of diabetes ranging between 11 and 15 years were at almost five-folded risk of developing DR compared to those with duration <10years. Most of advanced complicated diabetic retinopathy cases had diabetes more than fifteen years, and no advanced disease in the cases with duration less than 10 years.

The patients with poor controlled blood sugar and HbA1c >9 throughout the disease were at almost five-folded risk of developing DR compared to those with moderate controlled diabetes cases were HbA1c between (7.5 -9), patient with poor control of diabetes HbA1c>9 was 25-folded risk of developing PRP than cases with good control HbA1c <7.5. The majority of advanced diabetic retinopathy cases were correlated with non-controlled diabetes mellitus HbA1c > 9%, were no advanced complication recorded in good controlled cases.

The objective of this study to estimate the prevalence and identify the correlation between risk factors like age of patients, type of DM, duration, no control of diabetes mellitus patients with blindness due to progression of DR attending the Eye Department at Tobruk medical in Tobruk-Libya.

References

  1. Ahmed RA, Khalil SN and Al-Qahtani MA. “Diabetic retinopathy and the associated risk factors in diabetes type 2 patients in Abha, Saudi Arabia”. J Family Community Med 23.1 (2016): 18-24.
  2. Aiello LP., et al. “Diabetic retinopathy”. Diabetes Care 21 (1998): 143-56.
  3. Alali NM., et al. “Diabetic Retinopathy and Eye Screening: Diabetic Patients Standpoint, Their Practice, and Barriers; A Cross-Sectional Study”. J. Clin. Med 11 (2022): 6351.
  4. Alemu Mersha G., et al. “Prevalence of diabetic retinopathy among diabetic patients in Northwest Ethiopia—A cross sectional hospital based study”. PLoS ONE 17.1 (2022): e0262664.
  5. Alharbi AMD and Alhazmi AMS. “Prevalence, Risk Factors, and Patient Awareness of Diabetic Retinopathy in Saudi Arabia: A Review of the Literature”. Cureus 12.12 (2020): e11991.
  6. Ashraf M., et al. “Interaction Between the Distribution of Diabetic Retinopathy Lesions and the Association of Optical Coherence Tomography Angiography Scans With Diabetic Retinopathy Severity”. JAMA Ophthalmol 138.12 (2020): 1291-1297.
  7. Donald S Fong., et al. Diabetic Retinopathy Volume, American diabetic association 27.10 (2004).
  8. Flaxel CJ., et al. “Diabetic Retinopathy Preferred Practice Pattern®”. Ophthalmology. Jan;127.1 (2020): P66-P145. Epub 2019 Sep 25. Erratum in: Ophthalmology 127.9 (2020): 1279.
  9. Hafeez Mohammed., et al. “Correlation between Diabetic Retinopathy and Diabetic Peripheral Neuropathy in Patients with Type II Diabetes Mellitus”. Journal of Pharmacy And Bioallied Sciences 14(Suppl 1) (2022): S658-S661.
  10. Hassan Mohammed Hassan Hussien., et al. "Evaluation of the Choroid in Patients with Non Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography (OCTA)". Al-Azhar International Medical Journal 4.1 (2023).
  11. El-Bab MF., et al. “Retinopathy and risk factors in diabetic patients from Al-Madinah Al-Munawarah in the Kingdom of Saudi Arabia”. Clinical Ophthalmology 6 (2012): 269-276.
  12. Li X., et al. “Differential distribution of manifest lesions in diabetic retinopathy by fundus fluorescein angiography and fundus photography”. BMC Ophthalmol 20 (2020): 471.
  13. Moudgil T., et al. “Preferred practice pattern of physicians regarding diabetic retinopathy in diabetes mellitus patients”. Indian J Ophthalmol 69.11 (2021): 3139-3143.
  14. Mounirou BAM., et al. “Diabetic Retinopathy: An Overview of Treatments”. Indian J Endocrinol Metab 26.2 (2022): 111-118.
  15. Sahiledengle B., et al. “Prevalence and Factors Associated with Diabetic Retinopathy among Adult Diabetes Patients in Southeast Ethiopia: A Hospital-Based Cross-Sectional Study”. Clin Ophthalmol 16 (2022): 3527-3545.
  16. Salem A Alghamdi., et al. "Prevalence of retinopathy and associated risk factors among high- and low-risk patients with type 2 diabetes mellitus: An observational study". Saudi Med J 42.6 (2021): 693-697.
  17. Yasir ZH, Hassan AD and Rajiv K. “Diabetic retinopathy (DR) among 40 years and older Saudi population with diabetes in Riyadh governorate, Saudi Arabia - A population based survey”. Saudi J Ophthalmol 33.4 (2019): 363-368.